FR2947454B1 - INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES - Google Patents

INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES

Info

Publication number
FR2947454B1
FR2947454B1 FR0903234A FR0903234A FR2947454B1 FR 2947454 B1 FR2947454 B1 FR 2947454B1 FR 0903234 A FR0903234 A FR 0903234A FR 0903234 A FR0903234 A FR 0903234A FR 2947454 B1 FR2947454 B1 FR 2947454B1
Authority
FR
France
Prior art keywords
medicinal plants
pathologies
innovation
humans
indicated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0903234A
Other languages
French (fr)
Other versions
FR2947454A1 (en
Inventor
Dit Bon Michel Betend
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR0903234A priority Critical patent/FR2947454B1/en
Publication of FR2947454A1 publication Critical patent/FR2947454A1/en
Application granted granted Critical
Publication of FR2947454B1 publication Critical patent/FR2947454B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982—Reproductive organs; Embryos, Eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Medicamentous composition (I) comprises a mixture of a lyophilizate of one or more natural inhibitors of human proteases extracted from the egg white of quail Coturnix coturnix japonica(strain B.mina), and a lyophilizate of one or several entire medicinal plants, or one or more of their fractions and the combination consisting an active mixture. - ACTIVITY : Immunostimulant; Antiallergic; Antiinflammatory; Antimicrobial; Antiasthmatic; Anabolic. - MECHANISM OF ACTION : Human protease inhibitor.
FR0903234A 2009-07-02 2009-07-02 INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES Expired - Fee Related FR2947454B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0903234A FR2947454B1 (en) 2009-07-02 2009-07-02 INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903234A FR2947454B1 (en) 2009-07-02 2009-07-02 INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES

Publications (2)

Publication Number Publication Date
FR2947454A1 FR2947454A1 (en) 2011-01-07
FR2947454B1 true FR2947454B1 (en) 2011-09-02

Family

ID=41666428

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0903234A Expired - Fee Related FR2947454B1 (en) 2009-07-02 2009-07-02 INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES

Country Status (1)

Country Link
FR (1) FR2947454B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150057232A1 (en) * 2012-02-10 2015-02-26 Ovogenics Sa Anti-Inflammatory Composition for Modulating the Cell Response of Neutrophils and Eosinophils

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108158841B (en) * 2018-01-19 2022-02-01 中国农业大学 Application of active ingredient ovoninhibitor glycoprotein of quail eggs in antianaphylaxis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356426A1 (en) * 1976-06-29 1978-01-27 Truffier Jean Claude OVOMUCOID FRACTION OF QUAIL EGG WHITE, HAVING ANTIPROTEASIC PROPERTIES
FR2810550B1 (en) * 2000-06-27 2004-10-08 Medibrevex NOVEL SOLUBLE GALEIC FORMS OF QUAIL EGGS FOR MEDICINAL USE FOR EYE AND NASAL WASHING AND METHODS OF MAKING SAME
FR2838351B1 (en) * 2002-04-15 2006-07-14 Dit Bon Michel Betend NOVEL MEDICINAL SOLUTIONS ASSOCIATING JAPANESE QUAIL EGG WITH ORAL AND SUBLINGUAL MEDICINAL PLANTS IN ALLERGIES, GENERAL PATHOLOGY AND METHOD OF MANUFACTURING SAME
FR2901137B1 (en) * 2006-05-19 2013-01-25 Dit Bon Michel Betend NOVEL GALENIC FORMS OF NATURAL INHIBITORS OF PROTEASIC ENZYMES, QUAY EGG EXTRACTS ASSOCIATED WITH VITAMINS OR / AND MINERALS, AMINO ACIDS INCORPORATED INTO AN EXCIPIENT.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150057232A1 (en) * 2012-02-10 2015-02-26 Ovogenics Sa Anti-Inflammatory Composition for Modulating the Cell Response of Neutrophils and Eosinophils

Also Published As

Publication number Publication date
FR2947454A1 (en) 2011-01-07

Similar Documents

Publication Publication Date Title
CY1118519T1 (en) COMPOSITION OF TETRACYCLINS AND THEIR analogues
CY1119148T1 (en) PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF ADMINISTRATION
AR061930A1 (en) MIMETICBODIES OF GLP-1 HUMANS, COMPOSITIONS, METHODS AND USES
ES2499015T3 (en) Prophylactic or therapeutic agent for diarrhea
SV2008002511A (en) DIRECTED ANTIBODIES AGAINST BETA AMYLOID PEPTIDE AND METHODS USING THE SAME
CR9994A (en) THERAPEUTIC VACCINE
AR064363A1 (en) PIG TREATMENT WITH THE PCV ANTIGEN
DOP2011000264A (en) AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USES IN THERAPY
UY28757A1 (en) SUBSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
CO6351742A2 (en) ORGANIC COMPOUNDS FOR WOUND CICATRIZATION
NO20064953L (en) Human GLP-1 mimetic bodies, compositions, methods and applications
ECSP066670A (en) PRODUCTS FLORFENICOL WITH BETTER SOLUBILITY IN WATER
UY29377A1 (en) NEW LIQUID FORMULATIONS OF ROTAVIRUS, ITS PREPARATION AND ITS USES.
CO5611162A2 (en) METHODS TO PREVENT REPRODUCTIVE DISEASES IN VACCINE LIVESTOCK
BRPI0509271A (en) gastro-resistant pharmaceutical dosage forms comprising n- (2- (2-phthalimideethoxy) -acetyl-1-alanyl-d-glutamic acid (lk-4 23)
UY30762A1 (en) SMOKE SALT OF (ALFA S, BETA R) -6-BROMO-ALFA- [2 (DIMETILAMINO) ETIL] -2-METOXI-ALFA-1-NAFTALENIL-BETA-PHENYL-3-QUINOLINAETHANOL
AR067903A1 (en) METHOD TO TREAT STRESSED DEPRESSION
GT201400069A (en) PHARMACEUTICAL COMPOSITIONS
AR060565A1 (en) VACCINE FOR THE AVIARY FLU AND METHODS OF USE
ATE456369T1 (en) FLIBANSERIN FOR THE TREATMENT OF URINARY INCONTINENCE AND ASSOCIATED DISEASES
AR096854A1 (en) PHARMACEUTICAL COMPOSITION FOR A SUSTAINED RELEASE OF LANREOTIDE
GT200600263A (en) DOSAGE REGIME FOR PRASUGREL
ATE347358T1 (en) FLOATING ORAL FORMULATIONS WITH CONTROLLED RELEASE OF BETAIN
NI201100183A (en) CCR3 ANTAGONISTS OF ARYLSULFONAMIDE 2,5 - DISUSTITUTED
FR2947454B1 (en) INNOVATION FOR HUMANS AND ANIMALS BASED ON NATURAL INHIBITORS OF HUMAN PROTEASES ASSOCIATED WITH MEDICINAL PLANTS, INDICATED IN ALL PATHOLOGIES

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20200305